User:Mr. Ibrahem/Salmeterol

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Salmeterol
Clinical data
Trade namesSerevent, Aeromax, others
Other namesSalmeterol xinafoate
AHFS/Drugs.comMonograph
License data
Pregnancy
category
  • AU: B3
Routes of
administration
Respiratory inhalation (Metered-dose inhaler (MDI), Dry-powder inhaler (DPI))
Drug classLong-acting β2 adrenergic receptor agonist (LABA)[1]
Legal status
Legal status
Pharmacokinetic data
Protein binding96%
MetabolismLiver (CYP3A4)
Onset of actionAbout 30 min[1]
Elimination half-life5.5 hours
Duration of action12 hr[3]
Identifiers
  • (RS)-2-(hydroxymethyl)-4-{1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl}phenol
Chemical and physical data
FormulaC25H37NO4
Molar mass415.574 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • OCc1cc(ccc1O)[C@H](O)CNCCCCCCOCCCCc2ccccc2
  • InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2/t25-/m1/s1 checkY
  • Key:GIIZNNXWQWCKIB-RUZDIDTESA-N checkY
 ☒NcheckY (what is this?)  (verify)

Salmeterol, sold under the brand name Serevent among others, is a medication used in the maintenance of asthma or chronic obstructive pulmonary disease (COPD).[1] In asthma it is used together with a inhaled corticosteroid.[1] It is also used for exercise-induced bronchoconstriction.[1] Effects may begin in about 30 min and last about 12 hours.[1][3]

Common side effects include headache, runny nose, thrush, cough, and change in voice.[1] Other side effects may include low potassium, anaphylaxis, bronchospasm, and QT prolongation.[1] Use during pregnancy or breastfeeding is deemed reasonable.[3] It is a long-acting β2 adrenergic receptor agonist (LABA).[1]

Salmeterol was patented in 1983 and came into medical use in 1990.[4] In the United Kingdom 120 doses costs the NHS about £30 in 2021.[3] This amount in the United States costs about 800 USD.[5] It is also avaliable as fluticasone/salmeterol.[3]

References[edit]

  1. ^ a b c d e f g h i j k "Salmeterol". American Society of Health-System Pharmacists. Archived from the original on 25 July 2021. Retrieved 10 October 2021.
  2. ^ "Serevent Diskus- salmeterol xinafoate powder, metered". DailyMed. 13 January 2020. Archived from the original on 14 December 2020. Retrieved 6 September 2020.
  3. ^ a b c d e BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 266. ISBN 978-0-85711-369-6.{{cite book}}: CS1 maint: date format (link)
  4. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 543. ISBN 9783527607495. Archived from the original on 2021-07-24. Retrieved 2021-06-21.
  5. ^ "Salmeterol Xinafoate Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 10 October 2021.